Search

Author/Creator Edelman, Jonathan M.

1. Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial. Issue 2 (8th June 2017)

Authors:
Merkies, Ingemar S. J.; Lawo, John‐Philip; Edelman, Jonathan M.; De Bleecker, Jan L.; Sommer, Claudia; Robberecht, Wim; Saarela, Mika; Kamienowski, Jerzy; Stelmasiak, Zbigniew; Mielke, Orell; Tackenberg, Björn; Léger, Jean‐Marc
Other Names:
De Bleecker J. L. investigator.; Robberecht W. investigator.; Saarela M. investigator.; Franques J. investigator.; Léger J.‐M. investigator.; Juntas Morales R. investigator.; Sommer C. investigator.; Nguento A. investigator.; Schmidt J. investigator.; Schrey Ch. investigator.; Kamienowski J. inve...
Journal:
Journal of the peripheral nervous system
Issue:
Volume 22:Issue 2(2017)
Page Start:
149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency. (11th August 2017)

Authors:
Tortorici, Michael A.; Rogers, James A.; Vit, Oliver; Bexon, Martin; Sandhaus, Robert A.; Burdon, Jonathan; Chorostowska‐Wynimko, Joanna; Thompson, Philip; Stocks, James; McElvaney, Noel G.; Chapman, Kenneth R.; Edelman, Jonathan M.
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 11(2017)
Page Start:
2386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗